4th Quarter - Report

VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
—
Expenses
$630,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to corporate and international tax policy and research and development tax credits (no specific bills). Issues related to the Orphan Drug Tax Credit. Issues related to corporate and international tax policy in HR 5376, "Build Back Better Act," and related provisions debated in Senate (no specific bill).

LobbyistCovered position, as disclosed
KWAMME ANDERSON —
SCOTT BARNES —
MATTHEW O SCHUMAKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5376 (117th)

Health Issues HCR

Issues related to access to rare and orphan disease therapeutics under the enactment of ACA (no specific bills); Issues related to FDA regulatory pathways for pharmaceuticals (no specific bills); Issues related to pharmaceutical pricing (HR 3, "Elijah E. Cummings Lower Drug Costs Now Act"; HR 19, "Lower Costs, More Cures Act"; S 2164, "Lower Costs, More Cures Act"); S Res 477, expressing support for the designation of September 2021 as "Sickle Cell Disease Awareness Month"; HR 6000, "Cures 2.0"; and, Issues related to health care and prescription drug pricing in HR 5376, "Build Back Better Act," and Senate companion legislation (no specific bill).

LobbyistCovered position, as disclosed
KWAMME ANDERSON —
SCOTT BARNES —
MATTHEW O SCHUMAKER —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 5376 (117th), H.R. 3 (117th), H.R. 19 (117th), H.R. 6000 (117th), S.Res. 477 (117th)

Medicare/Medicaid MMM

Issues related to rare disease and orphan disease patient access in Medicaid (no specific bills).

LobbyistCovered position, as disclosed
KWAMME ANDERSON —
SCOTT BARNES —
MATTHEW O SCHUMAKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Issues related to funding for the Food and Drug Administration (S 2599 and HR 4356: "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022.")

LobbyistCovered position, as disclosed
SCOTT BARNES —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4356 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.